NmVac-4 A/C/Y/W-135  

 

             

 

 

 

 

 

Vaccine Products

    François   Espanola   العربية    中國  Thai        

 
 Home   About us   Patents   Vaccines Research  Clinical Trials Facilities   Investment  Global Health   Contact us 

SYMPTOMS OF BACTERIAL  MENINGITIS DISEASE

The common signs and symptoms of meningitis and septicemia. Others can include rapid breathing, diarrhea, stomach cramps and a rash that does not fade under pressure. In babies, check if the soft spot (fontanelle) on the top of the head is tense or bulging.

TODDLERS

 

High fever vomiting, diarrhea

High pitched moaning, cry

Blank, Pale, blotchy complexion

Baby dislike being handled

Difficult to wake or lethargic

CHILDREN & ADULTS

High fever, vomiting

Diarrhea

Severe headache

Neck stiffness

Joint or muscle pains

Dislike of bright lights

Drowsiness

Fits

 

MENINGOCOCCAL MENINGITIS VACCINES 

 

Meningitis vaccines meet the requirements established by the World Health Organization and U.S. and European Pharmacopoeia.

 

 

 

 

   

Meningococcal meningitis A/C/Y/W-135 Polysaccharide Vaccine - Freeze dried

(Serotypes A,C,Y,W-135) for Adults and Children - mVac-4 A/C/Y/W-135

Plain polysaccharide vaccine to protect from Meningococcal meningitis serogroups A, C, Y & W  (10-dose vials) for adults and children - 18-months protective immunity

PRODUCT BROCHUREAdobe Acrobat [pdf] file

Meningococcal Vaccine Products for Africa and Hajji

Clinically proven to be safe and efficacious; tests on 750 adults in Niger and Burkina Faso for a period of 56-weeks. pct fExpected to be in the market in 2010.

 
 

 Meningococcal meningitis A/C/Y/W-135 - DT Conjugate Vaccine - Liquid 

(Serotypes A,C,Y,W-135 Diphtheria Toxoid conjugate) - mVac-4 A/C/Y/W-135 DT™

for Adults, Children and infants < 5    D

Meningococcal meningitis serogroups A/C/Y/W-135 DT conjugated  vaccine for infants, children and adults 3 years protective immunity

Meningococcal DT conjugate Vaccine Product  Clinically proven to be safe and efficacious; tests on 100 children in  North Ivory Coast for a period of 56-weeks. 

Expected to be in the market in 2011.

 

Meningococcal meningitis A & C Vaccine - Freeze dried

(Serotypes A+C vaccine) for Adults and Children - Meningococcal A&C Vaccine

ITS NOT A JN PRODUCT 

Plain polysaccharide vaccine to protect from Neisseria meningitis serogroups A & C  (10-dose)  - 18-months protective immunity   

Meningococcal meningitis A&C Vaccine Product Clinically proven to be safe and efficacious since 30 years.    

PRODUCT BROCHUREAdobe Acrobat [pdf] file

NO ON-LINE ORDERS - e-MAIL THE REQUEST

  • Stock =  3,000,000 doses (2008-2009)

  • Cold Storage facility: Burkina Faso and Singapore - Store pickups are not acceptable 

  • Customers should prove to show Cold Chain handling and storage to be qualified for purchase.

  • - Ref - WHO guidelines

  • Contact us for volume discount and registration documents.

  • Credit up to 90-120 days on LC for qualified customers. 

  • Minimum order 100,000 doses; Special discount prices for NGO's.  

  • The product is registered in Ivory Coast, Burkina Faso, Niger, Togo, Benin, Senegal and other West Africa

  • This product is registered in West African countries, some of the South East Asia.  

  • Customers need to register in other areas please contact us for registration documents and samples.

     

    Orders strictly accepted from Africa, South East Asia, and Middle East -  Not for sale in the United States.

     

 

 

©1998-2005 JN International, Inc. All rights reserved